Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-09-25
2009-02-10
Desai, Rita J (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S268100
Reexamination Certificate
active
07488742
ABSTRACT:
A series of compounds represented by the structural formulasand pharmaceutically acceptable isomers, salts, solvates and polymorphs thereof are disclosed. Also disclosed are pharmaceutical compositions containing said compounds and their use as thrombin receptor antagonists and binders to cannabinoid receptors.
REFERENCES:
patent: 6063847 (2000-05-01), Chackalamannil et al.
patent: 6326380 (2001-12-01), Chackalamannil et al.
patent: 6645987 (2003-11-01), Chackalamannil et al.
patent: 6894065 (2005-05-01), Chackalamannil et al.
patent: 2004/0192753 (2004-09-01), Chackalamannil et al.
patent: WO 01/96330 (2001-12-01), None
Samuel Chackalamannil et al , Potent Non-Peptide thrombin Receptor Antagonists, 2003.
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358 & 365.
Int'l Search Report, Jun. 6, 2005.
Chackalamannil Samuel
Chelliah Mariappan V.
Xia Yan
Desai Rita J
Reinhardt Gerard E.
Schering Corporation
LandOfFree
Thrombin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thrombin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thrombin receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4055009